Mckesson Corporation
- UEI
- S1RUKWWRYFL6
- EIN
- 94-3207296
- SAM.gov registration
- Not checked yet
- Physical address
- 6555 STATE HWY 161, IRVING, TX 75039
Forensic summary
MCKESSON CORPORATION is a company based in Irving, Texas, and operates under its own name. In our records, the company has 239 contracts with the U.S. federal government, with a total obligated amount of $13.4 billion. The Department of Veterans Affairs is the largest single agency with which MCKESSON has done business, accounting for 98% of its total contract value. Other major agencies include the Department of Justice and the Department of Health and Human Services. The company's primary industries are pharmaceutical preparation manufacturing and drugs and druggists' sundries merchant wholesaling. MCKESSON is publicly traded under the stock ticker MCK. Its first contract in our database was recorded on October 1, 2025, and the latest was recorded on October 22, 2026.
MCKESSON CORPORATION has a risk score of 5 out of 100, indicating a low risk level. The only risk indicator identified is that its revenue is concentrated in a single agency, the Department of Veterans Affairs, which accounts for 98% of its total contract value. This concentration may indicate a potential dependency on one agency, which could pose a risk if that agency reduces its spending or changes its procurement practices. However, this is considered a statistical signal that merits review and not evidence of wrongdoing.
Written by AI only from the data on this page. Check the linked sources before relying on it.
Risk indicators
- Revenue concentrated in a single agency · share: 98%, agency: Department of Veterans Affairs+5
The score adds up statistical indicators from public records. It is a prompt for review, not evidence of wrongdoing.
Workplace safety (OSHA, last 10 years)
No OSHA inspections found for this establishment.
Matched by establishment name and ZIP code. An inspection does not imply a violation; penalties may be reduced on appeal. Source: U.S. Department of Labor.
Stock market and financials (SEC)
This company is publicly traded · MCK · SEC EDGAR
| Fiscal year | Revenue | Net income | Operating cash flow | Assets | Equity | Long-term debt |
|---|---|---|---|---|---|---|
| 2025 | $403.4B | $5.1B | $6.2B | — | — | — |
| 2024 | $359.1B | $3.5B | $6.1B | — | — | — |
| 2023 | $309B | $3.2B | $4.3B | — | — | — |
| 2022 | $276.7B | $3.7B | $5.2B | — | — | — |
| 2021 | $264B | $1.3B | $4.4B | — | — | — |
Material events (8-K), last 3 years
- Oct 6, 2026 8-K · Regulation FD disclosure
- Aug 28, 2026 8-K · Regulation FD disclosure
- Aug 5, 2026 8-K · Results of operations
- Jul 24, 2026 8-K · Shareholder vote
- Jul 1, 2026 8-K · Director or officer change, Regulation FD disclosure
- Jun 12, 2026 8-K · Material agreement, New financial obligation
- May 7, 2026 8-K · Results of operations
- Apr 28, 2026 8-K · Material agreement, Termination of material agreement, New financial obligation
- Apr 6, 2026 8-K · Material agreement, New financial obligation
- Mar 6, 2026 8-K · Regulation FD disclosure
- Mar 5, 2026 8-K · Director or officer change
- Feb 4, 2026 8-K · Results of operations
Annual figures from official SEC filings (XBRL). Dependence compares federal contracts signed by group companies in the last 12 months (total contract value, which may span several years) with the latest annual revenue: a reference, not an accounting figure. Stock prices are not included.
Digital presence and cybersecurity
mckesson.com · official website (Wikidata)
- ✓ Valid HTTPS
- ✓ HSTS enabled
- ✗ No Content Security Policy
- ✓ Clickjacking protection
- ✓ SPF strict (-all)
- ✓ DMARC reject
Detected technology: Google Analytics / Tag ManagerMarketojQuery
Passive check on Oct 29, 2026: only what any browser sees when opening the homepage and what the domain publishes in DNS (no scans or probing). It is a baseline best-practice reference, not a security audit; a missing header does not imply a vulnerability.
Legal identity and hierarchy (LEI)
LEI 549300WZWOM80UCFSF54 · Mckesson Corporation · US-DE · issued
- Mckesson Medical-Surgical Top Holdings INC. · US-FL
- Mckesson Uk Finance II Limited · GB
- P.C.B. · BE-BRU
Data from the Global Legal Entity Identifier Foundation (GLEIF), CC0 license. Each company self-reports its hierarchy when registering its LEI; many subsidiaries have no LEI of their own.
Transportation and logistics (USDOT / FMCSA)
All its USDOT registrations are inactive.
| USDOT | MC | Status | Operation | Fleet | Safety rating | Inspections 24m | Out-of-service (veh./driver) | Crashes 24m | Active insurance |
|---|---|---|---|---|---|---|---|---|---|
| 50541 IRVING, TX | — | Inactive | Interstate | 1 | — | — | — / — | — | — |
| 257500 PHOENIX, AZ | — | Inactive | Interstate | 0 | — | — | — / — | — | — |
| 280031 SAN FRANSISCO, CA | — | Inactive | Intrastate | 0 | — | — | — / — | — | — |
FMCSA open data (U.S. Department of Transportation): MCS-150 census, roadside inspections and crashes in the last 24 months, and insurance on file. Out-of-service rates are approximate (out-of-service violations per inspection of the relevant type). Large companies often register one USDOT number per division; they are linked by exact legal name.
Telecommunications (FCC)
Services: Private land mobile · 10
Licenses from the FCC Universal Licensing System (ULS) weekly full files; FCC ID grantees from the FCC's official registry. Linked by exact licensee legal name; every FCC ID starts with the grantee code.
Corporate governance (SEC)
Directors, officers and 10% owners
| Fraga Francisco | EVP, CIO and CTO | Oct 19, 2026 |
| Rodgers Thomas L | EVP, Chief Strategy & BDO | Jun 3, 2026 |
| Rutledge Napoleon B Jr | SVP, Controller & CAO | Sep 10, 2026 |
| Srinivasan Ramesh (Nmn) | EVP and Chief Strategy Officer | Aug 11, 2026 |
| Tyler Brian S. | Director · Chief Executive Officer | Jul 8, 2026 |
| Caruso Dominic J | Director | Jul 23, 2026 |
| Doughtie Lynne M | Director | Jul 23, 2026 |
| Dunbar Webster Roy | Director | Jul 23, 2026 |
| Dunsire Deborah | Director | Jul 23, 2026 |
| Gerberding Julie L. | Director | Jul 23, 2026 |
| Hinton James H. | Director | Jul 23, 2026 |
| Lerman Bradley E | Director | Aug 11, 2026 |
| Martinez Maria | Director | Jul 23, 2026 |
| Ozan Kevin M | Director | Jul 23, 2026 |
| Wilson-Thompson Kathleen | Director | Jul 23, 2026 |
Directors and owners from the latest Forms 3 and 4; subsidiaries from Exhibit 21 of the latest annual report (10-K). A name match does not prove identity. Source: SEC EDGAR.
Linked entities
No linked entities found.
Links come from shared physical addresses, reported executives and parent companies. A link is not an accusation.
Contract history
| Award | Agency | Description | Signed | Obligated | Mods | Obligated / ceiling | Competition |
|---|---|---|---|---|---|---|---|
| 15B20527F00000022 | Federal Prison System / Bureau Of Prisons | FY27 INTERAGENCY AGREEMENT PHARMACEUTICALS FOR FMC DEVENS. | Oct 22, 2026 | $2,000,000 | 0 | ×1.00 | Competed |
| 15B51926F00000155 | Federal Prison System / Bureau Of Prisons | BIKTARVY #376-0550 6624 BOTTLES | Sep 10, 2026 | $15,157,964 | 0 | ×1.00 | Competed |
| 36C24026K1011 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 AUG | Aug 1, 2026 | $1,159,388,670 | 0 | ×1.00 | Competed |
| 36C24026K1010 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JULY | Jul 1, 2026 | $1,194,619,137 | 0 | ×1.00 | Competed |
| 36C24026K1009 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JUNE | Jun 1, 2026 | $1,191,973,258 | 0 | ×1.00 | Competed |
| 36C24026K1008 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MAY | May 1, 2026 | $1,398,025,092 | 0 | ×1.00 | Competed |
| 75H71126F80034 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR (IDIQ) PURCHASES FOR NSSC CUSTOMERS. | Apr 10, 2026 | $9,000,000 | 0 | ×1.00 | Competed |
| 36C24026K1007 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 APRIL | Apr 1, 2026 | $1,191,348,081 | 0 | ×1.00 | Competed |
| 75H71126F80030 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PPV PURCHASES FOR NSSC CUSTOMERS. | Mar 30, 2026 | $9,000,000 | 0 | ×1.00 | Competed |
| 75H71126F80029 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR (IDIQ) PURCHASES FOR NSSC CUSTOMERS. | Mar 23, 2026 | $9,000,000 | 0 | ×1.00 | Competed |
| 36C24026K1006 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 MARCH | Mar 1, 2026 | $1,175,683,451 | 0 | ×1.00 | Competed |
| 75H71126F80024 | Indian Health Service | DELIVERY ORDER FOR ADDITIONAL FUNDING FOR NSSC PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR PURCHASES. | Feb 6, 2026 | $9,000,000 | 0 | ×1.00 | Competed |
| 36C24026K1005 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 FEBRUARY | Feb 1, 2026 | $1,060,268,795 | 0 | ×1.00 | Competed |
| 70CDCR26FR0000011 | U.S. Immigration And Customs Enforcement | THE PURPOSE OF THIS CONTRACT IS TO PROVIDE ICE HEALTH SERVICE CORPS WITH PHARMACEUTICAL PRODUCTS. | Jan 30, 2026 | $18,592,000 | 2 | ×1.00 | Competed |
| 75H71126F80018 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR PURCHASES FOR NSSC CUSTOMERS. | Jan 14, 2026 | $9,000,000 | 0 | ×1.00 | Competed |
| 36C24026K1004 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY | Jan 1, 2026 | $1,087,989,766 | 0 | ×1.00 | Competed |
| 75H71126F80016 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR PURCHASES FOR NSSC CUSTOMERS. | Dec 23, 2025 | $9,000,000 | 0 | ×1.00 | Competed |
| 15B10626F00000037 | Federal Prison System / Bureau Of Prisons | MCKESSON: NON-CONTROLLED MEDICATION DOS: OCTOBER 1, 2025 THRU DECEMBER 31, 2025. | Dec 3, 2025 | $24,534,880 | 6 | ×1.00 | Competed |
| 36C24026K1003 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER | Dec 1, 2025 | $1,110,402,104 | 0 | ×1.00 | Competed |
| 75H71126F80006 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR PURCHASES FOR NSSC FEDERAL CUSTOMERS. | Nov 14, 2025 | $9,000,000 | 0 | ×1.00 | Competed |
| 36C24026K1002 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER | Nov 1, 2025 | $1,406,868,182 | 0 | ×1.00 | Competed |
| 36C24026K1001 | Department Of Veterans Affairs | EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER | Oct 1, 2025 | $1,184,200,532 | 0 | ×1.00 | Competed |
| 75H71126F80023 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PPV PURCHASES FOR NSSC CUSTOMERS. | — | $8,000,000 | 0 | — | — |
| 75H71126F80009 | Indian Health Service | PHARMACEUTICAL SUPPLIES. PHARMACY PRIME VENDOR PURCHASES FOR NSSC FEDERAL CUSTOMERS. | — | $5,505,870 | 0 | — | — |
| 15B10626F00000172 | Federal Prison System / Bureau Of Prisons | MCKESSON: NON-CONTROLLED MEDICATION DOS: AUGUST 10, 2026- SEPTEMBER 30, 2026 | — | $5,000,000 | 0 | — | — |
| 15B50926F00000006 | Federal Prison System / Bureau Of Prisons | MCKESSON PHARMACEUTICALS FOR INMATES AT FMC FORT WORTH | — | $4,581,049 | 0 | — | — |
| 75H71126F80014 | Indian Health Service | PHARMACEUTICAL SUPPLIES. PHARMACY PRIME VENDOR PURCHASES FOR NSSC FEDERAL CUSTOMERS. | — | $4,500,000 | 0 | — | — |
| 15B51926F00000129 | Federal Prison System / Bureau Of Prisons | PHARMACEUTICALS | — | $4,460,593 | 0 | — | — |
| 75H71126F80013 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR PURCHASES FOR NSSC CUSTOMERS. | — | $4,000,000 | 0 | — | — |
| 75H71126F80035 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR (IDIQ) PURCHASES FOR NSSC CUSTOMERS. | — | $4,000,000 | 0 | — | — |
| 15B20526F00000003 | Federal Prison System / Bureau Of Prisons | PPV PHARMACEUTICAL ITEMS - FISCAL YEAR 26 | — | $3,464,920 | 0 | — | — |
| 75H71126F80005 | Indian Health Service | DELIVERY ORDER FOR PHARMACEUTICAL SUPPLIES, PRIME PHARMACY VENDOR PURCHASES FOR NSSC FEDERAL CUSTOMERS. | — | $3,358,127 | 0 | — | — |
| 70CDCR26FR0000037 | U.S. Immigration And Customs Enforcement | THIS CONTRACT IS TO RATIFY AN UNAUTHORIZED COMMITMENT FOR PHARMACEUTICALS FOR THE ICE HEALTH SERVICE CORPS. | — | $3,164,400 | 0 | — | — |
| 75H71126F80003 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PRIME PHARMACY VENDOR PURCHASES FOR NSSC FEDERAL CUSTOMERS. | — | $3,000,000 | 0 | — | — |
| 75H71126F80019 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PHARMACY PRIME VENDOR PURCHASES FOR NSSC CUSTOMERS. | — | $3,000,000 | 0 | — | — |
| 75H71126F80002 | Indian Health Service | PHARMACEUTICAL SUPPLIES, PPV PURCHASES FOR NSSC FEDERAL CUSTOMERS. | — | $2,819,494 | 0 | — | — |
| 15B51926F00000156 | Federal Prison System / Bureau Of Prisons | 322-9069 JARDIANCE 10MG 2940 BOTTLES | — | $2,439,524 | 0 | — | — |
| 15B20526F00000108 | Federal Prison System / Bureau Of Prisons | PPV PHARMACEUTICAL ITEMS | — | $2,247,849 | 0 | — | — |
| 75H71126F80001 | Indian Health Service | PHARMACEUTICAL SUPPLIES, OPEN MARKET PURCHASES FOR NSSC FEDERAL CUSTOMERS. | — | $2,000,000 | 0 | — | — |
| 15B10926F00000075 | Federal Prison System / Bureau Of Prisons | PHARMACEUTICAL PRIME VENDOR CONTRACT - MEDICATIONS FOR THE INMATE POPULATION | — | $1,899,069 | 0 | — | — |
| 15B61526F00000009 | Federal Prison System / Bureau Of Prisons | OATS - TCX-FY26-B1-MCKESSON-AIC PHARMACEUTICALS | — | $1,856,003 | 0 | — | — |
| 15B41726F00000006 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON CONTRACT ANNUAL | — | $1,616,794 | 0 | — | — |
| 75H71226F80005 | Indian Health Service | DELIVERY ORDER AGAINST 36W79720D0001, MCKESSON VA MEDSURGE PRIME VENDOR FOR PHARMACEUTICAL SUPPLIES FOR THE P… | — | $1,600,000 | 0 | — | — |
| 15B30326F00000002 | Federal Prison System / Bureau Of Prisons | FY 25 MCKESSON CONTRACT | — | $1,500,152 | 0 | — | — |
| 15B50526F00000172 | Federal Prison System / Bureau Of Prisons | FY 26 STANDARD MEDICATION - 4TH QTR JULY - SEPT | — | $1,472,476 | 0 | — | — |
| 15B50526F00000122 | Federal Prison System / Bureau Of Prisons | FY 26 STANDARD MEDICATION - APRIL - JUNE | — | $1,341,301 | 0 | — | — |
| 15B12026F00000005 | Federal Prison System / Bureau Of Prisons | FY26 MCKESSON MEDICATION 1ST QTR OCTOBER-DECEMBER 2025 | — | $1,275,615 | 0 | — | — |
| 15B50526F00000074 | Federal Prison System / Bureau Of Prisons | FY 26 STANDARD MEDICATION - JANUARY - MARCH | — | $1,251,354 | 0 | — | — |
| 15B51526F00000004 | Federal Prison System / Bureau Of Prisons | MCKESSON NON-CONTRACT MEDICATION 10/23/2025 THROUGH 10/31/2025. ACCOUNT NUMBER: 321045 | — | $1,146,029 | 0 | — | — |
| 15B20126F00000092 | Federal Prison System / Bureau Of Prisons | 4TH QUARTER REGULAR DRUGS COVERING 7/01/2026 THROUGH 9/30/2026 DELIVERY DATES FROM 7/01/2026 THROUGH 9/30/202… | — | $1,047,617 | 0 | — | — |
| 15B50526F00000032 | Federal Prison System / Bureau Of Prisons | FY 26 STANDARD MEDICATION | — | $1,024,614 | 0 | — | — |
| 15B51926F00000157 | Federal Prison System / Bureau Of Prisons | 368-6052 VOSEVI 54 BOTTLES | — | $1,017,949 | 0 | — | — |
| 15B61726F00000107 | Federal Prison System / Bureau Of Prisons | FCC LOMPOC MCKESSON REGULAR MEDICATIONS MARCH 1, 2026 - AUGUST 9, 2026 | — | $1,006,736 | 0 | — | — |
| 15B20526F00000135 | Federal Prison System / Bureau Of Prisons | PPV PHARMACEUTICAL ITEMS - OY3 FY26 AUG 10, 2026 - SEP 30, 2026 EO 14398 NEED INCREASE TO PAY OUTSTANDI… | — | $991,074 | 0 | — | — |
| 15B20126F00000078 | Federal Prison System / Bureau Of Prisons | 3RD QUARTER REGULAR DRUGS COVERING 4/01/2026 THROUGH 6/30/2026 DELIVERY DATES FROM 4/01/2026 THROUGH 6/30/202… | — | $949,985 | 0 | — | — |
| 15BBR026F00000013 | Federal Prison System / Bureau Of Prisons | PRIME VENDOR PHARMACEUTICAL FOR THE MDC BROOKLYN INMATE POPULATION | — | $894,494 | 0 | — | — |
| 15B60826F00000046 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON PHARMACUTICALS | — | $829,405 | 0 | — | — |
| 15B41826F00000054 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON REGULAR MEDICATION JAN26 | — | $825,521 | 0 | — | — |
| 15B31026F00000002 | Federal Prison System / Bureau Of Prisons | FY26 REGULAR MEDICATION (13F) - NOVEMBER 2025 -SEPTEMBER 2026 | — | $805,194 | 0 | — | — |
| 15B50126F00000070 | Federal Prison System / Bureau Of Prisons | MARCH MCKESSON CONTRACT MEDICATIONS FY26 | — | $780,928 | 0 | — | — |
| 15B50726F00000015 | Federal Prison System / Bureau Of Prisons | MCKESSON PRIME | — | $760,804 | 0 | — | — |
| 15B20126F00000057 | Federal Prison System / Bureau Of Prisons | 2ND QUARTER REGULAR DRUGS COVERING 1/01/2026 THROUGH 3/31/2026 DELIVERY DATES FROM 1/01/2026 THROUGH 3/31/202… | — | $750,000 | 0 | — | — |
| 15B30226F00000093 | Federal Prison System / Bureau Of Prisons | MCKESSON REGULAR MEDICATION AUGUST 2026 FISCAL YEAR 2026 RP#: 0167-26 | — | $741,496 | 0 | — | — |
| 15B51826F00000014 | Federal Prison System / Bureau Of Prisons | PROVIDE VARIOUS REGULAR MEDICATION FOR THE INMATE POPULATION AT FCC OAKDALE FOR FY26. | — | $727,616 | 0 | — | — |
| 15B10926F00000134 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES | — | $724,393 | 0 | — | — |
| 15B21726F00000006 | Federal Prison System / Bureau Of Prisons | INMATE MEDICATION FY26 | — | $712,496 | 0 | — | — |
| 15B41926F00000102 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON CONTRACT MEDICATIONS QTR 4 | — | $699,588 | 0 | — | — |
| 15B10926F00000057 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES | — | $696,289 | 0 | — | — |
| 15B30226F00000095 | Federal Prison System / Bureau Of Prisons | MCKESSON REGULAR MEDICATION SEPTEMBER 2026 FISCAL YEAR 2026 RP#: 0169-26 | — | $692,536 | 0 | — | — |
| 15B30226F00000085 | Federal Prison System / Bureau Of Prisons | MCKESSON REGULAR MEDICATION APRIL 2026 FISCAL YEAR 2026 RP#: 0159-26 | — | $690,388 | 0 | — | — |
| 15B10926F00000133 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES | — | $687,953 | 0 | — | — |
| 15B10926F00000082 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES | — | $684,907 | 0 | — | — |
| 15B20126F00000023 | Federal Prison System / Bureau Of Prisons | 1ST QUARTER REGULAR DRUGS COVERING 10/01/2025 THROUGH 12/31/2025 DELIVERY DATES FROM 10/01/2025 THROUGH 12/31… | — | $680,000 | 0 | — | — |
| 15B11926F00000029 | Federal Prison System / Bureau Of Prisons | FY26 MCKESSON MAT CONTRACT #36W79720D0001 | — | $677,866 | 0 | — | — |
| 15B60626F00000005 | Federal Prison System / Bureau Of Prisons | B1 - FY26 MCKESSON SAM OK | — | $665,000 | 0 | — | — |
| 15B10926F00000064 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES - ROUTINE WHOLESALE MEDICATION PURCHASES (MULTIPLE INVOI… | — | $646,780 | 0 | — | — |
| 15B31526F00000001 | Federal Prison System / Bureau Of Prisons | MEDICATION FOR THE INMATE POPULATION AT FCC YAZOO CITY FOR THE PERIOD OF PERFORMANCE: OCTOBER 1, 2025 - SEPTE… | — | $640,000 | 0 | — | — |
| 15B31426F00000053 | Federal Prison System / Bureau Of Prisons | B1- FY26 MCKESSON CONTRACT MEDICATION | — | $630,000 | 0 | — | — |
| 15B50226F00000012 | Federal Prison System / Bureau Of Prisons | FY 2026 NON-CONTROLLED PHARMACEUTICALS OCT. 2025 - JANUARY 30, 2026 | — | $604,462 | 0 | — | — |
| 15B41826F00000040 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON REGULAR MEDICATION DEC25 | — | $601,052 | 0 | — | — |
| 15B30226F00000091 | Federal Prison System / Bureau Of Prisons | MCKESSON REGULAR MEDICATION JULY 2026 FISCAL YEAR 2026 RP#: 0165-26 | — | $599,304 | 0 | — | — |
| 15B10926F00000061 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES | — | $599,111 | 0 | — | — |
| 15B30226F00000087 | Federal Prison System / Bureau Of Prisons | MCKESSON REGULAR MEDICATION MAY 2026 FISCAL YEAR 2026 RP#: 0161-26 | — | $582,727 | 0 | — | — |
| 15B40926F00000144 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON MEDICATION QTR 4 MEDICATION FOR INMATE HEALTHCARE | — | $573,353 | 0 | — | — |
| 15B10926F00000024 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES | — | $573,127 | 0 | — | — |
| 15B30226F00000064 | Federal Prison System / Bureau Of Prisons | MCKESSON REGULAR MEDICATION JANUARY 2025 FISCAL YEAR 2026 RP#: 0109-26 | — | $562,494 | 0 | — | — |
| 15B50826F00000004 | Federal Prison System / Bureau Of Prisons | REFERENCE CONTRACT #36W79720D0001, MCKESSON CORP. FOR INMATE PHARMACEUTICALS FOR A SERVICE PERIOD OF JANUARY… | — | $553,396 | 0 | — | — |
| 15B21526F00000091 | Federal Prison System / Bureau Of Prisons | MCKESSON FY26 MEDICATIONS | — | $552,393 | 0 | — | — |
| 15B41926F00000058 | Federal Prison System / Bureau Of Prisons | FCI THOMSON MCKESSON PHARMACEUTICALS ORDER FOR QUARTER THREE OF FY26. ORDER PLACED AGAINST CONTRACT 36W79720D… | — | $550,505 | 0 | — | — |
| 15B41826F00000025 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON REGULAR MEDICATION NOV25 | — | $546,424 | 0 | — | — |
| 15B50826F00000084 | Federal Prison System / Bureau Of Prisons | REFERENCE CONTRACT #36W79720D0001, MCKESSON CORP. FOR INMATE PHARMACEUTICALS FOR A SERVICE PERIOD OF JULY 1,… | — | $545,000 | 0 | — | — |
| 15B10926F00000011 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES - ROUTINE WHOLESALE MEDICATION PURCHASES (MULTIPLE INVOI… | — | $543,762 | 0 | — | — |
| 15B11926F00000010 | Federal Prison System / Bureau Of Prisons | FY26 MCKESSON GENERAL MEDICATIONS 10.01.25 - 01.31.26 CONTRACT #36W79720D0001 (VA IAA) | — | $537,996 | 0 | — | — |
| 15B10926F00000003 | Federal Prison System / Bureau Of Prisons | B1 MCKESSON NON-CONTROLLED AND CONTROLLED SUBSTANCES - ROUTINE WHOLESALE MEDICATION PURCHASES (MULTIPLE INVOI… | — | $532,652 | 0 | — | — |
| 15B61726F00000008 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON REGULAR MEDICATIONS DEC | — | $520,620 | 0 | — | — |
| 15B51826F00000092 | Federal Prison System / Bureau Of Prisons | PROVIDE VARIOUS REGULAR MEDICATION FOR THE INMATE POPULATION AT FCC OAKDALE FOR FY26. | — | $508,302 | 0 | — | — |
| 15B41226F00000041 | Federal Prison System / Bureau Of Prisons | FY26 B1 MCKESSON LD - PRIME VENDOR DEC 25 | — | $502,733 | 0 | — | — |
| 15B20127F00000020 | Federal Prison System / Bureau Of Prisons | 1ST QUARTER REGULAR DRUGS COVERING 10/01/2026 THROUGH 12/31/2026 DELIVERY DATES FROM 10/01/2026 THROUGH 12/31… | — | $500,000 | 0 | — | — |
| 75H71126F80007 | Indian Health Service | PHARMACEUTICAL SUPPLIES. PHARMACY PRIME VENDOR PURCHASES FOR NSSC FEDERAL CUSTOMERS. | — | $500,000 | 0 | — | — |
| 15B51926F00000108 | Federal Prison System / Bureau Of Prisons | JUNE MONTHLY MEDICATIONS FOR INMATES HOUSED AT FCC POLLOCK | — | $500,000 | 0 | — | — |